FDA Approves Bimzelx for Inflammatory Skin Disease
hidradenitis suppurativa © Lea - stock.adobe.comUCB announced today that the FDA has approved Bimzelx (bimekizumab-bkzx) for the treatment of moderate-to-severe...
hidradenitis suppurativa © Lea - stock.adobe.comUCB announced today that the FDA has approved Bimzelx (bimekizumab-bkzx) for the treatment of moderate-to-severe...
The FDA has accepted the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric...
1 Introduction Chronic inflammatory skin diseases (CISDs) are among the most common diseases in the Western world. A recent survey...